Raia Drogasil S.A.
RADLY
$2.86
-$0.319-10.05%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -4.21% | -3.08% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -4.21% | -3.08% | |||
| Cost of Revenue | -4.04% | -2.35% | |||
| Gross Profit | -4.61% | -4.77% | |||
| SG&A Expenses | 0.17% | -3.37% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 32.33% | 164.35% | |||
| Total Operating Expenses | -2.89% | -2.44% | |||
| Operating Income | -24.34% | -11.99% | |||
| Income Before Tax | -40.00% | -0.37% | |||
| Income Tax Expenses | -164.54% | 9.64% | |||
| Earnings from Continuing Operations | -2.63% | -3.03% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 102.80% | -88.94% | |||
| Net Income | -1.40% | -3.60% | |||
| EBIT | -24.34% | -11.99% | |||
| EBITDA | -19.29% | -10.48% | |||
| EPS Basic | -1.37% | 67.12% | |||
| Normalized Basic EPS | -27.78% | 45.66% | |||
| EPS Diluted | -0.82% | 66.21% | |||
| Normalized Diluted EPS | -27.20% | 44.51% | |||
| Average Basic Shares Outstanding | 0.01% | -42.50% | |||
| Average Diluted Shares Outstanding | -0.58% | -42.15% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | 203.29% | -1.00% | |||
